Phase II trial of topotecan, carboplatin, and paclitaxel as front-line therapy in suboptimal advanced epithelial ovarian cancer [2]

G. Bolis, G. Scarfone, A. Villa, F. Parazzini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)331-333
Number of pages3
JournalGynecologic Oncology
Issue number2
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this